One of the most frequent genetic mutations associated with the development of MM, BRAF, leads to the constitutive hyperactivation of the MAP kinase, followed by the activation of the ERK transcription factor and the excessive expression of the MMPs, transforming factor-beta and osteopontin genes, responsible for tumor growth, invasion, and metastases [2]. The gene discussed is SPP1; the disease is Miyoshi myopathy.